Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
European Urology|December 9, 2020
Outcomes in Patients with Muscle-invasive Bladder Cancer Treated with Neoadjuvant Chemotherapy Followed by (Chemo)radiotherapy in the BC2001 TrialSyed A Hussain, Nuria Porta, Emma Hall, et al.
Targeted Oncology|May 31, 2022
A Phase 2 Trial of Afatinib in Patients with Solid Tumors that Harbor Genomic Aberrations in the HER family: The MOBILITY3 Basket StudyAbdulazeez Salawu, Aaron R Hansen, Anna Spreafico, et al.
Cancer Medicine|July 15, 2026
Impact of Frontline Systemic Treatment Choice on Clinical Outcome in Advanced Leiomyosarcoma: A CanSaRCC StudyErica C Koch Hein, Abha Gupta, Hagit Peretz Soroka, et al.
Gynecologic Oncology|August 4, 2019
When to stop human chorionic gonadotrophin (hCG) surveillance after treatment with chemotherapy for gestational trophoblastic neoplasia (GTN): A national analysis on over 4,000 patientsKirsty Balachandran, Abdulazeez Salawu, Ehsan Ghorani, et al.
Targeted Oncology|June 18, 2024
Safety and Preliminary Efficacy of Once-Weekly Split-Dose Selinexor in Soft Tissue Sarcoma: Results of the Phase Ib METSSAR Clinical TrialAbdulazeez Salawu, Eoghan R Malone, Esmail Al-Ezzi, et al.
The Pan African Medical Journal|September 3, 2020
Oncology practice in the COVID-19 pandemic: a report of a Nigerian expert panel discussion (oncology care in Nigeria during the COVID-19 pandemic)Adeniyi Adedayo Olabumuyi, Musa Ali-Gombe, Olusegun Abayomi Biyi-Olutunde, et al.
Clinical Chemistry|June 27, 2018
Genome-Wide Analysis of Circulating Cell-Free DNA Copy Number Detects Active Melanoma and Predicts SurvivalShobha Silva, Sarah Danson, Dawn Teare, et al.
Lung Cancer (Amsterdam, Netherlands)|November 7, 2020
Oncolytic herpesvirus therapy for mesothelioma - A phase I/IIa trial of intrapleural administration of HSV1716Sarah J Danson, Joe Conner, John G Edwards, et al.
NPJ Precision Oncology|May 5, 2026
Predicting immunotherapy benefit in leiomyosarcoma through active chromatin cfDNA profilingCarlos Diego Holanda Lopes, Hsin-Ta Wu, Katharine Dilger, et al.
Current Oncology (Toronto, Ont.)|May 26, 2026
A Consensus Approach to the Incorporation of Total Neoadjuvant Therapy in a Treatment Algorithm for Stage I-III Resectable Rectal CancerSami A Chadi, Karineh Kazazian, Paul Savage, et al.
Pageof 3